Wordt geladen...
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2017
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/ https://ncbi.nlm.nih.gov/pubmed/28953318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|